1. Home
  2. CTMX vs TCBX Comparison

CTMX vs TCBX Comparison

Compare CTMX & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • TCBX
  • Stock Information
  • Founded
  • CTMX 2008
  • TCBX 2008
  • Country
  • CTMX United States
  • TCBX United States
  • Employees
  • CTMX N/A
  • TCBX N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • TCBX Banks
  • Sector
  • CTMX Health Care
  • TCBX Finance
  • Exchange
  • CTMX Nasdaq
  • TCBX Nasdaq
  • Market Cap
  • CTMX 596.2M
  • TCBX 481.8M
  • IPO Year
  • CTMX 2015
  • TCBX 2021
  • Fundamental
  • Price
  • CTMX $3.32
  • TCBX $37.63
  • Analyst Decision
  • CTMX Strong Buy
  • TCBX Hold
  • Analyst Count
  • CTMX 5
  • TCBX 4
  • Target Price
  • CTMX $5.80
  • TCBX $41.33
  • AVG Volume (30 Days)
  • CTMX 3.0M
  • TCBX 67.9K
  • Earning Date
  • CTMX 11-07-2025
  • TCBX 10-22-2025
  • Dividend Yield
  • CTMX N/A
  • TCBX N/A
  • EPS Growth
  • CTMX 263.20
  • TCBX 61.17
  • EPS
  • CTMX 0.49
  • TCBX 4.13
  • Revenue
  • CTMX $141,100,000.00
  • TCBX $192,224,000.00
  • Revenue This Year
  • CTMX N/A
  • TCBX $23.66
  • Revenue Next Year
  • CTMX N/A
  • TCBX $6.46
  • P/E Ratio
  • CTMX $6.79
  • TCBX $9.07
  • Revenue Growth
  • CTMX 18.01
  • TCBX 20.96
  • 52 Week Low
  • CTMX $0.40
  • TCBX $25.17
  • 52 Week High
  • CTMX $3.91
  • TCBX $41.25
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 55.87
  • TCBX 44.31
  • Support Level
  • CTMX $3.21
  • TCBX $37.50
  • Resistance Level
  • CTMX $3.91
  • TCBX $40.58
  • Average True Range (ATR)
  • CTMX 0.26
  • TCBX 1.35
  • MACD
  • CTMX -0.06
  • TCBX -0.05
  • Stochastic Oscillator
  • CTMX 30.59
  • TCBX 20.69

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: